Drawing for QIAXTRACTOR

USPTO serial 79071657

QIAXTRACTOR

Reviewed by CopyMark Law Group

Reg. 3845402Status 404
Filing date
Status date
Registration date
Sep 7, 2010
Examiner
MORENO, PAUL A
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QIAXTRACTOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roxana A. Sullivan

Roxana A. Sullivan Dennemeyer & Associates, LLC181 W Madison Street, Suite 4500Chicago, IL 60602UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form and magnetic particles in fluid form, none of the foregoing for medical or veterinary purposes; materials for columns and reagents and solvents for sample preparation, all of the foregoing for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; kits comprising chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, in particular nucleic acids made from biological and biochemical sample material, none of the foregoing for medical or veterinary purposes ]SECTION 7(e) - CANCELLED—
005[ Products for medical and veterinary medical purposes, in particular diagnostic preparations, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer chemicals and aqueous and non- aqueous solutions of primary, secondary and tertiary alcohols and salts, distilled and purified water, magnetic particles in fluid form, and materials for reaction vessels for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, all of the foregoing for medical and veterinary purposes; products for medical and veterinary medical purposes, namely, chemical, biochemical and biotechnological products as well as kits comprising products for medical and veterinary medical purposes, in particular chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, genetic information and conditions of the human body ]SECTION 7(e) - CANCELLED—
009Scientific apparatus, instruments and equipment for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis and industrial use, namely, nucleic acid purifiers, [ sequencers, polymerase chain reaction (PCR) cyclers, thermocyclers, electroporators, pipetting equipment, incubators, laboratory centrifuges; laboratory equipment ] and automated laboratory equipment, namely, apparatus for extraction, [ analysis and handling of nucleic acids, ] nucleic acid extractors and automated nucleic acid extractors; parts and accessories for the foregoing, namely, robotic parts, pumps, carbon-filter purifiers, waste collection apparatus and bottles, filter cartridges, UV light sterilizers, reagent tubs, sample containers, holders for containers, pipette tips, pipette tip holders, pipetting aides, microplates; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, automated nucleic acid extractors; computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verificationSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2019DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 18, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 7, 2019REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jan 30, 2018INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jan 20, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 7, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
May 25, 2017INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 25, 2017INPCINVALIDATION PROCESSED—
May 20, 2017NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 20, 201771AGREGISTERED-SEC.71 ACCEPTED—
May 20, 2017C7P.CANCELLED SEC. 7 - PARTIAL—
May 16, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 15, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 10, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 9, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 24, 2017C7PFRQST FOR SECT 7 PARTIAL SURRENDER FILED—
Jan 24, 2017ES7STEAS SECTION 7 SURRENDER RECEIVED—
Dec 16, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 16, 2016NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Sep 16, 201615AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Sep 16, 2016PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Sep 16, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 11, 2016ES75TEAS SECTION 71 & 15 RECEIVED—
Feb 13, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 20, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 17, 2010FIMPFINAL DISPOSITION PROCESSED—
Dec 7, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 27, 2010CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 7, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 22, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 22, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 19, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 18, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 12, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 12, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 12, 2010ALIEASSIGNED TO LIE—
Apr 1, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 1, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2009RFNTREFUSAL PROCESSED BY IB—
Oct 5, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 5, 2009RFRRREFUSAL PROCESSED BY MPU—
Oct 3, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 2, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2009RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Sep 25, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 24, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 11, 2009DOCKASSIGNED TO EXAMINER—
Sep 11, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 10, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance